- Report
- February 2025
- 141 Pages
Global
From €3540EUR$3,950USD£3,037GBP
- Report
- December 2023
- 117 Pages
Global
From €3988EUR$4,450USD£3,421GBP
- Report
- July 2024
- 306 Pages
Global
From €4477EUR$4,995USD£3,840GBP
- Report
- October 2022
- 120 Pages
Global
From €3226EUR$3,600USD£2,768GBP
- Report
- October 2022
- 53 Pages
Europe
From €1344EUR$1,500USD£1,153GBP
- Report
- February 2025
- 111 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- June 2025
- 86 Pages
Asia Pacific
From €3540EUR$3,950USD£3,037GBP
- Report
- June 2025
- 89 Pages
Europe
From €3540EUR$3,950USD£3,037GBP
- Report
- June 2025
- 86 Pages
North America
From €3092EUR$3,450USD£2,653GBP
- Report
- June 2025
- 103 Pages
Global
From €3092EUR$3,450USD£2,653GBP
- Report
- June 2025
- 74 Pages
From €3092EUR$3,450USD£2,653GBP
- Report
- June 2025
- 71 Pages
Africa, Middle East
From €3092EUR$3,450USD£2,653GBP
- Report
- June 2025
- 175 Pages
Global
From €4436EUR$4,950USD£3,806GBP
- Report
- February 2023
- 50 Pages
China
From €2689EUR$3,000USD£2,307GBP
- Report
- October 2024
- 92 Pages
Global
From €3500EUR$4,184USD£3,108GBP
- Report
- August 2024
- 77 Pages
Global
From €3500EUR$4,184USD£3,108GBP
- Report
- January 2025
- 132 Pages
Global
From €851EUR$950USD£730GBP
- Report
- October 2024
- 70 Pages
Global
From €851EUR$950USD£730GBP
- Report
- October 2024
- 70 Pages
North America
From €851EUR$950USD£730GBP
- Report
- October 2024
- 70 Pages
Asia Pacific
From €851EUR$950USD£730GBP

The Artificial Organ market is a subset of the Biomaterials industry, which focuses on the development of materials for use in medical applications. Artificial organs are designed to replace or supplement the function of a damaged or missing organ, and can be made from a variety of materials, including polymers, metals, and ceramics. These materials are chosen for their biocompatibility, durability, and ability to interact with the body's natural systems.
The Artificial Organ market is driven by advances in medical technology, as well as the increasing prevalence of chronic diseases and organ failure. The market is expected to grow in the coming years, as more people seek out treatments for their conditions.
Companies in the Artificial Organ market include Abiomed, SynCardia Systems, and WorldHeart Corporation. Show Less Read more